XIAP antisense

XIAP antisense oligonucleotide · Aegera Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XIAP antisense, covering 2009-12-01 to 2009-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML [Phase 1, Phase 2]